Poly(ADP-Ribose) Polymerase 1 Inhibition Improves Coronary Arteriole Function in Type 2 Diabetes Mellitus

No abstract is available for this paper.

• Publication year

  2012

• Venue

  HYPERTENSION

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.111.190140PMID 22454481PMCID PMC3331962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice.

  2011cited by this paper
• Interleukin-10 Released by CD4+CD25+ Natural Regulatory T Cells Improves Microvascular Endothelial Function Through Inhibition of NADPH Oxidase Activity in Hypertensive Mice

  2011cited by this paper
• Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer

  2010cited by this paper
• ADP-Ribose ) Polymerase as a Novel Therapeutic get in Cancer

  2010cited by this paper
• Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications.

  2010cited by this paper
• Poly ADP-ribose polymerase-1 and health

  2010cited by this paper
• PARP inhibitors: new tools to protect from inflammation.

  2010cited by this paper
• The potential role and application of PARP inhibitors in cancer treatment.

  2008cited by this paper
• PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.

  2008cited by this paper
• Elevated Epidermal Growth Factor Receptor Phosphorylation Induces Resistance Artery Dysfunction in Diabetic db/db Mice

  2008influential reference
• NSCLC: Primary Tumor Size – Radiation Dose-related Accelerated, Twice Daily Radiotherapy by Target Splitting, Preceded by 2 Cycles of Chemotherapy – First Results of a Prospective Study

  2007cited by this paper
• Hind limb ischemia-reperfusion in the leptin receptor deficient (db/db) mouse.

  2007cited by this paper
• Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models

  2007cited by this paper
• ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

  2007cited by this paper
• Altered Endothelial Nitric Oxide Synthase Targeting and Conformation and Caveolin-1 Expression in the Diabetic Kidney

  2006cited by this paper
• Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions

  2006cited by this paper
• THE PARP-1 INHIBITOR INO-1001 FACILITATES HEMODYNAMIC STABILIZATION WITHOUT AFFECTING DNA REPAIR IN PORCINE THORACIC AORTIC CROSS-CLAMPING-INDUCED ISCHEMIA/REPERFUSION

  2006cited by this paper
• Endothelial dysfunction in type 2 diabetes mellitus.

  2006cited by this paper
• Nitric Oxide-dependent Negative Feedback of PARP-1 trans-Activation of the Inducible Nitric-oxide Synthase Gene*

  2006cited by this paper
• Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

  2005cited by this paper
• ROLE OF ENDOTHELIUM‐DERIVED HYPERPOLARIZING FACTOR IN ENDOTHELIAL DYSFUNCTION DURING DIABETES

  2005cited by this paper
• Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.

  2005cited by this paper
• Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal.

  2005cited by this paper
• Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone.

  2005cited by this paper
• Angiotensin II-Mediated Endothelial Dysfunction: Role of Poly(ADP-ribose) Polymerase Activation

  2004cited by this paper
• Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.

  2004cited by this paper
• Transduction of NO-bioactivity by the red blood cell in sepsis: novel mechanisms of vasodilation during acute inflammatory disease.

  2004cited by this paper
• Pharmacological modulation of Poly(ADP-ribose) polymerase-mediated cell death: exploitation in cancer chemotherapy.

  2003cited by this paper
• Molecular motors

  2003cited by this paper
• PARP-1--a Perpetrator of Apoptotic Cell Death?

  2002cited by this paper
• Cell biology. PARP-1--a perpetrator of apoptotic cell death?

  2002cited by this paper
• Influence of Type II Diabetes on Arterial Tone and Endothelial Function in Murine Mesenteric Resistance Arteries

  2001cited by this paper
• Physiology and pathophysiology of poly(ADP‐ribosyl)ation *

  2001cited by this paper
• Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

  2001influential reference
• Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension.

  2000cited by this paper
• Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes.

  1999cited by this paper
• Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin

  1999cited by this paper
• Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q).

  1999cited by this paper
• Poly(ADP-ribose) polymerase: a molecular nick-sensor.

  1994cited by this paper
• Assessment of radiation-induced DNA damage in human blood lymphocytes using the single-cell gel electrophoresis technique.

  1992cited by this paper
• Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced beta-cell toxicity in vivo and in vitro.

  1990cited by this paper
• Oxygen Free-Radical Scavengers and Immune Destruction of Murine Islets in Allograft Rejection and Multiple Low-Dose Streptozocin-Induced Insulitis

  1989cited by this paper

• Exploring molecular disparities of H-type vasculature endothelial cells in osteonecrosis of the femoral head through single-cell analysis

  2025cites this paper
• METTL3-dependent m6A modification of SNAP29 induces “autophagy-mitochondrial crisis” in the ischemic microenvironment after soft tissue transplantation

  2025cites this paper
• Types, Molecular Mechanisms and Potential Therapeutic Targets of Programmed Endothelial Cell Death in Atherosclerosis.

  2025cites this paper
• "Yin-Yang" of PARP1 in genotoxic and inflammatory response.

  2025cites this paper
• Poly (ADP-ribose) Polymerase-1 modulations in the genesis of thrombosis

  2024cites this paper
• Exercise protects aged mice against coronary endothelial senescence via FUNDC1-dependent mitophagy.

  2023cites this paper
• Plasmacytoid dendritic cells contribute to vascular endothelial dysfunction in type 2 diabetes

  2023cites this paper
• Different types of cell death in diabetic endothelial dysfunction.

  2023cites this paper
• Bidirectional regulation role of PARP-1 in high glucose-induced endothelial injury.

  2022cites this paper
• ROS-triggered endothelial cell death mechanisms: Focus on pyroptosis, parthanatos, and ferroptosis

  2022cites this paper
• Disrupting Interleukin 12 Improves Microvascular Endothelial Function in Type 2 Diabetes Through ER Stress CHOP and Oxidative Stress Mechanisms

  2022cites this paper
• PARP1 deficiency protects against hyperglycemia-induced neointimal hyperplasia by upregulating TFPI2 activity in diabetic mice

  2021cites this paper
• Mechanism of the switch from NO to H2O2 in endothelium-dependent vasodilation in diabetes

  2021cites this paper
• Coronary Microvascular Dysfunction in Diabetes – Clinical and Research

  2020cites this paper
• Poly(ADP-ribose) polymerase inhibition: past, present and future

  2020cites this paper
• Endothelial Dysfunction and Passive Changes in the Aorta and Coronary Arteries of Diabetic db/db Mice

  2020cites this paper
• Poly(ADP-Ribose) Polymerase Activity and Coronary Artery Disease in Type 2 Diabetes Mellitus

  2020cites this paper
• Stimulation of autophagy improves vascular function in the mesenteric arteries of type 2 diabetic mice

  2019cites this paper
• DNA fragmentation index, pAKT and pERK1/2 in cumulus cells are related to oocyte competence in patients undergoing in vitro fertilization programme

  2019influential citation
• Arsenic, Cadmium, and Lead Like Troglitazone Trigger PPARγ-Dependent Poly (ADP-Ribose) Polymerase Expression and Subsequent Apoptosis in Rat Brain Astrocytes

  2018cites this paper
• PARP‐1 inhibition protects the diabetic heart through activation of SIRT1‐PGC‐1&agr; axis☆

  2018cites this paper
• Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders

  2018cites this paper
• Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice

  2018cites this paper
• 1,25(OH)2D3 improves cardiac dysfunction, hypertrophy, and fibrosis through PARP1/SIRT1/mTOR‐related mechanisms in type 1 diabetes

  2017cites this paper
• Current perspectives in coronary microvascular dysfunction

  2017cites this paper
• Poly(ADP‐ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II

  2017cites this paper
• Targeting endothelial metaflammation to counteract diabesity cardiovascular risk: Current and perspective therapeutic options

  2017cites this paper
• PARP-1 Variant Rs1136410 Confers Protection against Coronary Artery Disease in a Chinese Han Population: A Two-Stage Case-Control Study Involving 5643 Subjects

  2017cites this paper
• Gene Expression and Apoptosis Levels in Cumulus Cells of Patients with Polymorphisms of FSHR and LHB Undergoing in Vitro Fertilization Program

  2017cites this paper
• Relationship between apoptosis and survival molecules in human cumulus cells as markers of oocyte competence

  2017influential citation
• Inhibition of endoplasmic reticulum stress improves coronary artery function in type 2 diabetic mice

  2016cites this paper
• PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals.

  2016cites this paper
• Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade

  2016cites this paper
• NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair

  2016cites this paper
• Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic mice

  2015cites this paper
• Differential role for stromal interacting molecule 1 in the regulation of vascular function

  2015cites this paper
• Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity

  2015cites this paper
• Translation of sphingosine-1-phosphate-dependent regulation of myogenic tone in human resistance arteries with heart failure

  2015cites this paper
• Enhanced p22phox expression impairs vascular function through p38 and ERK1/2 MAP kinase-dependent mechanisms in type 2 diabetic mice.

  2014cites this paper
• Enhanced p 22 phox expression impairs vascular function through p 38 and ERK 1 / 2 MAP kinase-dependent mechanisms in type 2 diabetic mice

  2014cites this paper
• Poly(ADP‐ribose) Polymerase 1 (PARP1) in Atherosclerosis: From Molecular Mechanisms to Therapeutic Implications

  2014cites this paper
• Diabetes and Microvascular Dysfunction

  2014cites this paper
• Association of three SNPs in the PARP-1 gene with Hashimoto’s thyroiditis

  2014cites this paper
• Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

  2013cites this paper
• Enhanced NF-κB Activity Impairs Vascular Function Through PARP-1–, SP-1–, and COX-2–Dependent Mechanisms in Type 2 Diabetes

  2013cites this paper
• Discussion of PARP inhibitors in cancer therapy.

  2013cites this paper
• Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice.

  2013cites this paper
• Vascular Health and Risk Management Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus

  2013cites this paper
• Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus

  2013cites this paper